Smoking and airway innate host defense: in vivo studies
吸烟和气道先天宿主防御:体内研究
基本信息
- 批准号:7231810
- 负责人:
- 金额:$ 45.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-12-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Healthy smokers (without COPD) have increased occurrence of airway infections compared to non-smokers,
and smoking is also the major risk factor for COPD. COPD is characterized by chronic airway obstruction,
decreased mucociliary clearance (MCC), mucus hypersecretion, and chronic airway inflammation. Bacterial
and viral infections are the leading causes of acute exacerbations of COPD. . In Cystic Fibrosis (CF),
dehydration of the airway surface liquid (ASL) leads to decreased mucociliary clearance (MCC), colonization
by bacteria and frequent exacerbations of disease related to MCC failure. The CFTR-induced anomalies in
ASL solute concentration and subsequent ASL dehydration are a central cause of CF lung disease. Clinical
similarities between COPD and Cystic Fibrosis (CF) suggest that despite differences in pathogenesis, there
are key similarities in their pathophysiology. Adenosine and purinergic control of airway hydration are likely
important in both diseases, as we have observed that (like CF) COPD patients also have decreased ASL
dehydration and adenosine levels relative to normal volunteers. The overarching hypothesis of this project is
that smoking predisposes to decreased MCC due to ASL dehydration, partly due to decreased ASL
adenosine and diminished innate host defense. In Project IV, we will test the hypothesis that smokers have
decreased MCC with alterations in purine and adenosine biology by comparing these airway processes
between normal volunteers and smokers. We also hypothesize that smoking will cause decreased
macrophage function and bacterial colonization of the airway. We will compare our results in normal
volunteers and smokers to those from similarly studied COPD (Project V) and CF (Project VI) patients, as we
suspect that smoking-induced changes will mimic those in COPD. We will also examine MCC, hydration and
airway responses in normal volunteers and smokers after challenge with inhaled endotoxin (a bacterial
product found in tobacco smoke) and experimental viral infection to determine if MCC in smokers is less
adaptive to these challenges. These aims will provide novel in vivo data on smoking-induced airway
pathophysiology in humans. The medical significance of these studies is that they will firmly establish the
importance of mucus clearance to maintain respiratory health and will elucidate disease mechanisms and
therapeutic targets applicable for many chronic obstructive airway diseases.
健康吸烟者(无COPD)与非吸烟者相比,气道感染的发生率增加,
吸烟也是COPD的主要危险因素。COPD的特征在于慢性气道阻塞,
降低的粘液纤毛清除率(MCC)、粘液分泌过多和慢性气道炎症。细菌
病毒感染是COPD急性加重的主要原因。.在囊性纤维化(CF)中,
气道表面液体(ASL)的脱水导致粘膜纤毛清除率(MCC)降低,
与MCC失败相关的疾病的频繁恶化。CFTR引起的异常,
ASL溶质浓度和随后的ASL脱水是CF肺病的主要原因。临床
COPD和囊性纤维化(CF)之间的相似性表明,尽管发病机制不同,
在病理生理学上有着关键的相似之处腺苷和嘌呤能控制气道水化可能是
在这两种疾病中都很重要,因为我们观察到(像CF一样)COPD患者也有ASL降低,
脱水和腺苷水平相对于正常志愿者。这个项目的首要假设是
吸烟易导致由于ASL脱水而导致的MCC减少,部分原因是由于ASL减少
腺苷和减弱的先天宿主防御。在项目IV中,我们将测试吸烟者有
通过比较这些气道过程,减少MCC与嘌呤和腺苷生物学的改变
正常志愿者和吸烟者之间的差异。我们还假设吸烟会导致
巨噬细胞功能和气道细菌定植。我们将比较我们的结果在正常
志愿者和吸烟者与类似研究的COPD(项目V)和CF(项目VI)患者相比,
怀疑吸烟引起的变化将模仿COPD中的变化。我们还将检查MCC,水合作用和
正常志愿者和吸烟者吸入内毒素(一种细菌)后的气道反应
烟草烟雾中发现的产品)和实验性病毒感染以确定吸烟者中的MCC是否较少
适应这些挑战。这些目标将提供新的吸烟诱导气道的体内数据
人类的病理生理学这些研究的医学意义在于,它们将坚定地确立
粘液清除对维持呼吸系统健康的重要性,并将阐明疾病机制,
适用于许多慢性阻塞性气道疾病的治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David B. Peden其他文献
Impact of Aeroallergen Sensitization on Asthma Control in African-American Teens with Persistent Asthma
空气过敏原敏化对患有持续性哮喘的非洲裔美国青少年哮喘控制的影响
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
A. Burbank;S. Grabich;Krista Todorich;Marcia Frye;C. Loughlin;Kelly Duncan;C. Robinette;K. Mills;David B. Peden;David Diaz;Michelle L. Hernandez - 通讯作者:
Michelle L. Hernandez
Airway cells from atopic asthmatic patients exposed to ozone display an enhanced innate immune gene profile
- DOI:
10.1016/j.jaci.2011.11.007 - 发表时间:
2012-01-01 - 期刊:
- 影响因子:
- 作者:
Michelle Hernandez;Willie June Brickey;Neil E. Alexis;Rebecca C. Fry;Julia E. Rager;Baiming Zhou;Jenny P.Y. Ting;Haibo Zhou;David B. Peden - 通讯作者:
David B. Peden
Effect of prednisone on woodsmoke-induced sputum inflammation in healthy volunteers: A randomized, placebo-controlled pilot study
- DOI:
10.1016/j.jacig.2024.100347 - 发表时间:
2025-02-01 - 期刊:
- 影响因子:
- 作者:
Terry L. Noah;Neil E. Alexis;William D. Bennett;Michelle L. Hernandez;Allison J. Burbank;Haolin Li;Haibo Zhou;Ilona Jaspers;David B. Peden - 通讯作者:
David B. Peden
Global change, climate change, and asthma in children: Direct and indirect effects - A WAO Pediatric Asthma Committee Report
全球变化、气候变化与儿童哮喘:直接和间接影响——世界过敏组织儿科哮喘委员会报告
- DOI:
10.1016/j.waojou.2024.100988 - 发表时间:
2024-11-01 - 期刊:
- 影响因子:4.300
- 作者:
Peter N. Le Souëf;Yuichi Adachi;Eleni Anastasiou;Ignacio J. Ansotegui;Héctor A. Badellino;Tina Banzon;Cesar Pozo Beltrán;Gennaro D'Amato;Zeinab A. El-Sayed;Rene Maximiliano Gómez;Elham Hossny;Ömer Kalayci;Mário Morais-Almeida;Antonio Nieto-Garcia;David B. Peden;Wanda Phipatanakul;Jiu-Yao Wang;I-Jen Wan;Gary Wong;Paraskevi Xepapadaki;Nikolaos G. Papadopoulos - 通讯作者:
Nikolaos G. Papadopoulos
David B. Peden的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David B. Peden', 18)}}的其他基金
Research Training in Allergy and Clinical Immunology
过敏和临床免疫学研究培训
- 批准号:
10493540 - 财政年份:2022
- 资助金额:
$ 45.34万 - 项目类别:
Research Training in Allergy and Clinical Immunology
过敏和临床免疫学研究培训
- 批准号:
10686797 - 财政年份:2022
- 资助金额:
$ 45.34万 - 项目类别:
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic
项目 4:用新型粘液溶解剂治疗哮喘粘膜淤积和气道阻塞
- 批准号:
10001602 - 财政年份:2017
- 资助金额:
$ 45.34万 - 项目类别:
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic
项目 4:用新型粘液溶解剂治疗哮喘粘膜淤积和气道阻塞
- 批准号:
9356821 - 财政年份:2017
- 资助金额:
$ 45.34万 - 项目类别:
Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation
γ-生育酚化学预防木烟PM2.5引起的气道炎症
- 批准号:
9222012 - 财政年份:2016
- 资助金额:
$ 45.34万 - 项目类别:
Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation
γ-生育酚化学预防木烟PM2.5引起的气道炎症
- 批准号:
9883794 - 财政年份:2016
- 资助金额:
$ 45.34万 - 项目类别:
Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation
γ-生育酚化学预防木烟PM2.5引起的气道炎症
- 批准号:
9055845 - 财政年份:2016
- 资助金额:
$ 45.34万 - 项目类别:
Phase II studies of gamma tocopherol as an intervention for environmental asthma
γ-生育酚作为环境性哮喘干预措施的 II 期研究
- 批准号:
9269215 - 财政年份:2013
- 资助金额:
$ 45.34万 - 项目类别:
Phase II studies of gamma tocopherol as an intervention for environmental asthma
γ-生育酚作为环境性哮喘干预措施的 II 期研究
- 批准号:
8598698 - 财政年份:2013
- 资助金额:
$ 45.34万 - 项目类别:
Phase II studies of gamma tocopherol as an intervention for environmental asthma
γ-生育酚作为环境性哮喘干预措施的 II 期研究
- 批准号:
8733697 - 财政年份:2013
- 资助金额:
$ 45.34万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 45.34万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 45.34万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 45.34万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 45.34万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 45.34万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 45.34万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 45.34万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 45.34万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 45.34万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 45.34万 - 项目类别: